- Home
- SGHT vs CTGO Comparison
SGHT vs CTGO Comparison
Compare SGHT & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- CTGO
- Stock Information
- Founded
- SGHT 2011
- CTGO 2009
- Country
- SGHT United States
- CTGO United States
- Employees
- SGHT N/A
- CTGO N/A
- Industry
- SGHT Medical Specialities
- CTGO Precious Metals
- Sector
- SGHT Health Care
- CTGO Basic Materials
- Exchange
- SGHT Nasdaq
- CTGO Nasdaq
- Market Cap
- SGHT 140.1M
- CTGO 151.1M
- IPO Year
- SGHT 2021
- CTGO N/A
- Fundamental
- Price
- SGHT $3.22
- CTGO $13.97
- Analyst Decision
- SGHT Buy
- CTGO Strong Buy
- Analyst Count
- SGHT 7
- CTGO 1
- Target Price
- SGHT $3.83
- CTGO $37.00
- AVG Volume (30 Days)
- SGHT 189.8K
- CTGO 159.0K
- Earning Date
- SGHT 05-08-2025
- CTGO 05-13-2025
- Dividend Yield
- SGHT N/A
- CTGO N/A
- EPS Growth
- SGHT N/A
- CTGO N/A
- EPS
- SGHT N/A
- CTGO N/A
- Revenue
- SGHT $79,866,000.00
- CTGO N/A
- Revenue This Year
- SGHT N/A
- CTGO N/A
- Revenue Next Year
- SGHT $11.17
- CTGO N/A
- P/E Ratio
- SGHT N/A
- CTGO N/A
- Revenue Growth
- SGHT N/A
- CTGO N/A
- 52 Week Low
- SGHT $2.03
- CTGO $8.85
- 52 Week High
- SGHT $8.45
- CTGO $25.32
- Technical
- Relative Strength Index (RSI)
- SGHT 67.25
- CTGO 71.30
- Support Level
- SGHT $2.40
- CTGO $13.01
- Resistance Level
- SGHT $3.44
- CTGO $15.24
- Average True Range (ATR)
- SGHT 0.28
- CTGO 1.04
- MACD
- SGHT 0.11
- CTGO 0.30
- Stochastic Oscillator
- SGHT 84.40
- CTGO 92.32
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About CTGO Contango ORE Inc.
Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.